ARTICLE SUMMARY:
Devices driven by artificial intelligence algorithms are becoming more prevalent in healthcare, but reimbursement remains a challenge. Deborah Godes from McDermott+Consulting spoke to Market Pathways on the topic, offering insights for companies entering the coverage, coding, and payment trenches for AI tech in the latest "From the Experts" column.
AI-driven technologies such as imaging analysis algorithms are increasingly making their way through FDA review and edging into clinical practice, but for clinicians to leverage AI more routinely, the tools must be integrated and appropriately valued within the reimbursement system.
